D. Calmday-Ombo

Aframomum Melegueta Attenuates Doxorubicin-Induced Hepatic Fibrogenesis Via Redox Modulation and Antifibrotic Activity

Doxorubicin is an effective anthracycline chemotherapeutic agent whose clinical use is limited by dose-dependent hepatotoxicity characterized by oxidative stress and progressive hepatic fibrosis. Aframomum melegueta, a medicinal plant rich in antioxidant phytochemicals, has shown promising pharmacological properties; h...